SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed herewith our Press Release relating to launch of ILUMYA(r) (tildrakizumab) for treatment of plaque psoriasis in Japan. Sun Pharma Advanced Research gains over 3% on pact with Tripoint Therapeutics
Sun Pharma Advanced Research Company on Tuesday announced the grant of an exclusive licence to Tripoint Therapeutics LLC, USA to commercialise the Ele
Buy Sun Pharmaceuticals; target of Rs 660: Dolat Capital
Dolat Capital is bullish on Sun Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 660 in its research report dated September 21, 2020. Stock picks by Prabhudas Lilladher: Buy Take Solutions, Sun Pharma
Sun Pharma's stock is in a rising trend SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 04, 2020 for Smt. Kumud S Shanghvi SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 04, 2020 for Shanghvi Finance Pvt Ltd SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Intimation Of Record Date For Redemption Of Commercial Paper
Pursuant to SEBI circular no. SEBI/HO/DDHS/CIR/P/2019/115 dated October 22, 2019 this is to inform you that Tuesday, September 8, 2020 is the record date to determine the holders of Commercial Papers (CPs) of the Company whose names stand registered in the Register of Beneficial Owners maintained by Depositories in respect of the CPs held in electronic form under ISIN No. INE044A14575 and who are entitled to receive payment towards redemption amount on the Maturity Date i.e. September 9, 2020. SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Sun Pharmaceutical Industries Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Voting Results of 28th Annual General Meeting of the Company held on August 27, 2020 in accordance with Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 along with Scrutinizer''s Consolidated Report SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 28, 2020 for Shanghvi Finance Pvt Ltd